Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.
Papasavvas E, Kostman JR, Mounzer K, Grant RM, Gross R, Gallo C, Azzoni L, Foulkes A, Thiel B, Pistilli M, Mackiewicz A, Shull J, Montaner LJ. Papasavvas E, et al. Among authors: kostman jr. PLoS Med. 2004 Dec;1(3):e64. doi: 10.1371/journal.pmed.0010064. Epub 2004 Dec 28. PLoS Med. 2004. PMID: 15630469 Free PMC article. Clinical Trial.
HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption.
Papasavvas E, Kostman JR, Thiel B, Pistilli M, Mackiewicz A, Foulkes A, Gross R, Jordan KA, Nixon DF, Grant R, Poulin JF, McCune JM, Mounzer K, Montaner LJ. Papasavvas E, et al. Among authors: kostman jr. J Clin Immunol. 2006 Jan;26(1):40-54. doi: 10.1007/s10875-006-7518-8. J Clin Immunol. 2006. PMID: 16418802 Clinical Trial.
Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy.
Papasavvas E, Azzoni L, Pistilli M, Hancock A, Reynolds G, Gallo C, Ondercin J, Kostman JR, Mounzer K, Shull J, Montaner LJ. Papasavvas E, et al. Among authors: kostman jr. AIDS. 2008 Jun 19;22(10):1153-61. doi: 10.1097/QAD.0b013e328303be2a. AIDS. 2008. PMID: 18525261 Free PMC article. Clinical Trial.
HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjects.
Papasavvas E, Moore EC, Sun J, Azzoni L, Pistilli M, Mounzer K, Shull J, Kostman JR, Montaner LJ. Papasavvas E, et al. Among authors: kostman jr. AIDS Res Hum Retroviruses. 2008 Sep;24(9):1203-8. doi: 10.1089/aid.2008.0054. AIDS Res Hum Retroviruses. 2008. PMID: 18788911 Free PMC article.
Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients.
Papasavvas E, Foulkes A, Yin X, Joseph J, Ross B, Azzoni L, Kostman JR, Mounzer K, Shull J, Montaner LJ. Papasavvas E, et al. Among authors: kostman jr. Immunology. 2015 Jul;145(3):380-90. doi: 10.1111/imm.12452. Epub 2015 May 19. Immunology. 2015. PMID: 25684333 Free PMC article.
Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint.
Giron LB, Papasavvas E, Azzoni L, Yin X, Anzurez A, Damra M, Mounzer K, Kostman JR, Sanne I, Firnhaber CS, Tateno H, Liu Q, Montaner LJ, Abdel-Mohsen M. Giron LB, et al. Among authors: kostman jr. AIDS. 2020 Apr 1;34(5):681-686. doi: 10.1097/QAD.0000000000002476. AIDS. 2020. PMID: 31972605 Free PMC article.
127 results